List of Roxybond drug patents

Roxybond is owned by Protega Pharms.

Roxybond contains Oxycodone Hydrochloride.

Roxybond has a total of 2 drug patents out of which 0 drug patents have expired.

Roxybond was authorised for market use on 20 April, 2017.

Roxybond is available in tablet;oral dosage forms.

The generics of Roxybond are possible to be released after 12 August, 2028.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7955619 PROTEGA PHARMS Abuse resistant drugs, method of use and method of making
Aug, 2028

(5 years from now)

US10314788 PROTEGA PHARMS Pharmaceutical compositions configured to deter dosage form splitting
Aug, 2028

(5 years from now)

Drugs and Companies using OXYCODONE HYDROCHLORIDE ingredient

Market Authorisation Date: 20 April, 2017

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage

ROXYBOND family patents

28

United States

5

Australia

3

Canada

2

Japan

2

China

2

European Union

1

Poland

1

Mexico

1

Spain

1

Brazil

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in